Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,126,512
Closed -$63.6M 96
2018
Q3
$63.6M Buy
1,126,512
+666,408
+145% +$34.7M 0.93% 43
2018
Q2
$21.3M Buy
+460,104
New +$20.9M 0.33% 88
2017
Q3
Sell
-535,232
Closed -$19.3M 89
2017
Q2
$19.3M Sell
535,232
-472,896
-47% -$17.5M 0.52% 60
2017
Q1
$36.2M Buy
+1,008,128
New +$33.2M 0.91% 47
2016
Q4
Sell
-3,509,392
Closed -$99.2M 94
2016
Q3
$99.2M Buy
3,509,392
+2,986,752
+571% +$79.1M 2.9% 6
2016
Q2
$12.5M Sell
522,640
-3,816,372
-88% -$94.8M 0.38% 66
2016
Q1
$118M Buy
+4,339,012
New +$108M 3.65% 3
2015
Q3
Sell
-2,573,348
Closed -$80.7M 76
2015
Q2
$80.7M Buy
2,573,348
+850,700
+49% +$27.2M 2.04% 16
2015
Q1
$53.6M Buy
+1,722,648
New +$52M 1.48% 28
2013
Q4
Sell
-3,021,760
Closed -$51.5M 62
2013
Q3
$51.5M Buy
+3,021,760
New +$50.1M 1.24% 26

Other funds holding AAPL

PFM Health Sciences's AAPL Position: Q4 2018 in Review

PFM Health Sciences sold out of Apple (AAPL) in Q4 2018, closing a stake of 1,126,512 shares — an estimated $63.6M sold.

PFM Health Sciences first reported a position in AAPL in Q3 2013 and held it in 10 quarters. The position peaked at $118M in Q1 2016. 3,039 funds tracked by Wall St. Rank hold AAPL as of Q4 2018.

  • PFM Health Sciences reported no remaining Apple position as of Q4 2018 after selling out during the quarter.
  • PFM Health Sciences sold 1,126,512 Apple shares in Q4 2018, an estimated $63.6M.
  • PFM Health Sciences first reported a position in Apple in Q3 2013 and held it in 10 quarters.
  • PFM Health Sciences's Apple position peaked at $118M in Q1 2016.
  • 3,039 funds tracked by Wall St. Rank held Apple as of Q4 2018.

Based on PFM Health Sciences's 13F filing for Q4 2018, filed 14 Feb 2019.